During the past decade, UCLA School of Medicine, Department of Neurology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA School of Medicine, Department of Neurology" are "Epilepsy" (1 trials), "Epilepsy, Temporal Lobe" (1 trials), "Glioma" (1 trials) and "Seizures" (1 trials). Many other conditions were trialed in "UCLA School of Medicine, Department of Neurology" in a lesser frequency.

Most popular intervention types in "UCLA School of Medicine, Department of Neurology" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "RTA 744" (1 trials), "RTA 744 injection" (1 trials), "anteromesial temporal resection" (1 trials) and "antiepileptic drugs" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA School of Medicine, Department of Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA School of Medicine, Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UCLA School of Medicine, Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA School of Medicine, Department of Neurology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".